Latest developments in engineered skeletal muscle tissues for drug discovery and development

dc.authoridFujie, Toshinori/0000-0003-1417-8670
dc.authoridKaji, Hirokazu/0000-0003-2566-4172
dc.authoridRamalingam, Murugan/0000-0001-6498-9792
dc.authoridostrovidov, serge/0000-0002-4189-8086
dc.authoridbae, hojae/0000-0003-3057-4999
dc.authorscopusid6602776344
dc.authorscopusid59176479500
dc.authorscopusid35799555800
dc.authorscopusid6602772615
dc.authorscopusid12801720000
dc.authorscopusid55617444400
dc.authorscopusid55617444400
dc.authorwosidShi, Xuetao/D-5180-2012
dc.authorwosidFujie, Toshinori/O-1493-2018
dc.authorwosidKaji, Hirokazu/T-2219-2019
dc.authorwosidRamalingam, Murugan/AAV-1702-2020
dc.contributor.authorOstrovidov, Serge
dc.contributor.authorRamalingam, Murugan
dc.contributor.authorBae, Hojae
dc.contributor.authorOrive, Gorka
dc.contributor.authorFujie, Toshinori
dc.contributor.authorShi, Xuetao
dc.contributor.authorKaji, Hirokazu
dc.date.accessioned2024-07-05T15:24:08Z
dc.date.available2024-07-05T15:24:08Z
dc.date.issued2023
dc.departmentAtılım Universityen_US
dc.department-temp[Ostrovidov, Serge; Kaji, Hirokazu] Tokyo Med & Dent Univ TMDU, Inst Biomat & Bioengn IBB, Dept Biomech, Tokyo, Japan; [Ramalingam, Murugan] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan, South Korea; [Ramalingam, Murugan] Dankook Univ, PLUS NBM Global Res Ctr, Dept Nanobiomed Sci, BK21,Regenerat Med Res Ctr, Cheonan, South Korea; [Ramalingam, Murugan] Chengdu Univ, Sch Basic Med Sci, Chengdu, Sichuan, Peoples R China; [Bae, Hojae] Konkuk Univ, KU Convergence Sci & Technol Inst, Dept Stem Cell & Regenerat Biotechnol, Hwayang dong,Kwangjin Gu, Seoul, South Korea; [Orive, Gorka] Univ Basque Country UPV, Vitoria-gasteiz, Spain; [Orive, Gorka] Univ Basque Country UPV, Sch Pharm, Lab Pharmaceut, NanoBioCel Grp, Vitoria, Spain; [Orive, Gorka] Biomed Res Networking Ctr Bioengn, Biomat & Nanomed CIBER BBN, Vitoria, Spain; [Fujie, Toshinori] Tokyo Inst Technol, Dept Life Sci & Technol, Yokohama, Japan; [Shi, Xuetao] South China Univ Technol, Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou, Guangdong, Peoples R China; [Ramalingam, Murugan] Dankook Univ, Mechanobiol Dent Med Res Ctr, Cheonan, South Korea; [Ramalingam, Murugan] Atilim Univ, Dept Met & Mat Engn, Ankara, Turkeyen_US
dc.descriptionFujie, Toshinori/0000-0003-1417-8670; Kaji, Hirokazu/0000-0003-2566-4172; Ramalingam, Murugan/0000-0001-6498-9792; ostrovidov, serge/0000-0002-4189-8086; bae, hojae/0000-0003-3057-4999en_US
dc.description.abstractIntroductionWith the advances in skeletal muscle tissue engineering, new platforms have arisen with important applications in biology studies, disease modeling, and drug testing. Current developments highlight the quest for engineering skeletal muscle tissues with higher complexity . These new human skeletal muscle tissue models will be powerful tools for drug discovery and development and disease modeling.Areas coveredThe authors review the latest advances in in vitro models of engineered skeletal muscle tissues used for testing drugs with a focus on the use of four main cell culture techniques: Cell cultures in well plates, in microfluidics, in organoids, and in bioprinted constructs. Additional information is provided on the satellite cell niche.Expert opinionIn recent years, more sophisticated in vitro models of skeletal muscle tissues have been fabricated. Important developments have been made in stem cell research and in the engineering of human skeletal muscle tissue. Some platforms have already started to be used for drug testing, notably those based on the parameters of hypertrophy/atrophy and the contractibility of myotubes. More developments are expected through the use of multicellular types and multi-materials as matrices . The validation and use of these models in drug testing should now increase.en_US
dc.description.sponsorshipJapan Society for the Promotion of Science (JSPS) KAKENHI [22K18936, 21K04852]; AMED [JP21gm1310001]; JST Adaptable and Seamless Technology Transfer Program through Target-driven RD [JPMJTM22BD, JPMJTM22BE]; CASIO SCIENCE PROMOTION FOUNDATION; Research Center for Biomedical Engineering at Tokyo Medical and Dental University, Japan; Spanish Ministry of Economy, Industry, and Competitiveness [PID2019-106094RB-I00/AEI]; Grants-in-Aid for Scientific Research [22K18936] Funding Source: KAKENen_US
dc.description.sponsorshipThis work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Numbers 22K18936 and 21K04852); AMED (Grant Number JP21gm1310001); JST Adaptable and Seamless Technology Transfer Program through Target-driven R&D (Grant Numbers JPMJTM22BD and JPMJTM22BE); CASIO SCIENCE PROMOTION FOUNDATION, and the Research Center for Biomedical Engineering at Tokyo Medical and Dental University, Japan. Furthermore, G Orive thanks the Spanish Ministry of Economy, Industry, and Competitiveness (PID2019-106094RB-I00/AEI/10.13039/501100011033) for their support.en_US
dc.identifier.citation3
dc.identifier.doi10.1080/17460441.2023.2160438
dc.identifier.endpage63en_US
dc.identifier.issn1746-0441
dc.identifier.issn1746-045X
dc.identifier.issue1en_US
dc.identifier.pmid36535280
dc.identifier.scopus2-s2.0-85145288436
dc.identifier.scopusqualityQ1
dc.identifier.startpage47en_US
dc.identifier.urihttps://doi.org/10.1080/17460441.2023.2160438
dc.identifier.urihttps://hdl.handle.net/20.500.14411/2397
dc.identifier.volume18en_US
dc.identifier.wosWOS:000903993900001
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBioprintingen_US
dc.subjectdrug developmenten_US
dc.subjectdrug evaluationen_US
dc.subjectmicrofluidicsen_US
dc.subjectmuscle skeletalen_US
dc.subjectorganoidsen_US
dc.subjectstem cellsen_US
dc.titleLatest developments in engineered skeletal muscle tissues for drug discovery and developmenten_US
dc.typeReviewen_US
dspace.entity.typePublication

Files

Collections